Suppr超能文献

来自重叠黏粒片段的爱泼斯坦-巴尔病毒重组体。

Epstein-Barr virus recombinants from overlapping cosmid fragments.

作者信息

Tomkinson B, Robertson E, Yalamanchili R, Longnecker R, Kieff E

机构信息

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.

出版信息

J Virol. 1993 Dec;67(12):7298-306. doi: 10.1128/JVI.67.12.7298-7306.1993.

Abstract

Five overlapping type 1 Epstein-Barr virus (EBV) DNA fragments constituting a complete replication- and transformation-competent genome were cloned into cosmids and transfected together into P3HR-1 cells, along with a plasmid encoding the Z immediate-early activator of EBV replication. P3HR-1 cells harbor a type 2 EBV which is unable to transform primary B lymphocytes because of a deletion of DNA encoding EBNA LP and EBNA 2, but the P3HR-1 EBV can provide replication functions in trans and can recombine with the transfected cosmids. EBV recombinants which have the type 1 EBNA LP and 2 genes from the transfected EcoRI-A cosmid DNA were selectively and clonally recovered by exploiting the unique ability of the recombinants to transform primary B lymphocytes into lymphoblastoid cell lines. PCR and immunoblot analyses for seven distinguishing markers of the type 1 transfected DNAs identified cell lines infected with EBV recombinants which had incorporated EBV DNA fragments beyond the transformation marker-rescuing EcoRI-A fragment. Approximately 10% of the transforming virus recombinants had markers mapping at 7, 46 to 52, 93 to 100, 108 to 110, 122, and 152 kbp from the 172-kbp transfected genome. These recombinants probably result from recombination among the transfected cosmid-cloned EBV DNA fragments. The one recombinant virus examined in detail by Southern blot analysis has all the polymorphisms characteristic of the transfected type 1 cosmid DNA and none characteristic of the type 2 P3HR-1 EBV DNA. This recombinant was wild type in primary B-lymphocyte infection, growth transformation, and lytic replication. Overall, the type 1 EBNA 3A gene was incorporated into 26% of the transformation marker-rescued recombinants, a frequency which was considerably higher than that observed in previous experiments with two-cosmid EBV DNA cotransfections into P3HR-1 cells (B. Tomkinson and E. Kieff, J. Virol. 66:780-789, 1992). Of the recombinants which had incorporated the marker-rescuing cosmid DNA fragment and the fragment encoding the type 1 EBNA 3A gene, most had incorporated markers from at least two other transfected cosmid DNA fragments, indicating a propensity for multiple homologous recombinations. The frequency of incorporation of the nonselected transfected type 1 EBNA 3C gene, which is near the end of two of the transfected cosmids, was 26% overall, versus 3% in previous experiments using transfections with two EBV DNA cosmids. In contrast, the frequency of incorporation of a 12-kb EBV DNA deletion which was near the end of two of the transfected cosmids was only 13%.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

构成一个完整的具有复制和转化能力基因组的五个重叠的1型爱泼斯坦-巴尔病毒(EBV)DNA片段被克隆到黏粒中,并与一个编码EBV复制的Z立即早期激活剂的质粒一起转染到P3HR-1细胞中。P3HR-1细胞携带2型EBV,由于编码EBNA LP和EBNA 2的DNA缺失,它无法转化原代B淋巴细胞,但P3HR-1 EBV可以提供反式复制功能,并能与转染的黏粒重组。通过利用重组体将原代B淋巴细胞转化为淋巴母细胞系的独特能力,选择性地克隆回收了来自转染的EcoRI-A黏粒DNA且具有1型EBNA LP和2基因的EBV重组体。对1型转染DNA的七个鉴别标记进行的PCR和免疫印迹分析,鉴定出感染了EBV重组体的细胞系,这些重组体整合的EBV DNA片段超出了拯救转化标记的EcoRI-A片段。大约10%的转化病毒重组体具有的标记位于距172kbp转染基因组7、46至52、93至100、108至110、122和152kbp处。这些重组体可能是由转染的黏粒克隆的EBV DNA片段之间的重组产生的。通过Southern印迹分析详细检测的一个重组病毒具有转染的1型黏粒DNA的所有多态性特征,而没有2型P3HR-1 EBV DNA的特征。该重组体在原代B淋巴细胞感染、生长转化和裂解复制方面是野生型。总体而言,1型EBNA 3A基因整合到了26%的拯救转化标记的重组体中,这一频率明显高于先前将两个黏粒EBV DNA共转染到P3HR-1细胞中的实验中观察到的频率(B. Tomkinson和E. Kieff,《病毒学杂志》66:780-789,1992)。在整合了拯救标记的黏粒DNA片段和编码1型EBNA 3A基因的片段的重组体中,大多数还整合了来自至少两个其他转染的黏粒DNA片段的标记,表明存在多次同源重组的倾向。位于两个转染黏粒末端附近的未选择的转染1型EBNA 3C基因的整合频率总体为26%,而在先前使用两个EBV DNA黏粒转染的实验中为3%。相比之下,位于两个转染黏粒末端附近的12kb EBV DNA缺失的整合频率仅为13%。(摘要截短至400字)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b95b/238193/a28e45778586/jvirol00033-0399-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验